 clinical experimental study all-trans retinoic acid-treated acute promyelocytic leukemia patients Fifty patients acute promyelocytic leukemia APL all-trans retinoic acid RA vitro induced differentiation bone marrow cells patients colony-forming unit granulocyte-macrophage CFU-GM L-CFU colony-forming assays karyotype analysis treatment course high bone complete remission CR rate all-trans RA superior conventional chemotherapeutic regimens treatment APL leukemic clone RA-induced terminal differentiation loss proliferation capacity leukemic cells Relapse CR patients major reason failure RA treatment Patients chemotherapy-maintained CR second CR RA relapse CR RA chemotherapy sensitivity leukemic clones RA RA conventional chemotherapy CR Laboratory studies valuable cases RA therapy therapeutic effects prognosis